You are here: Home » News-CM » Companies » News
Business Standard

Sun Pharma update on USFDA inspection of its Dadra facility

Capital Market 

Receives copy of EIR from USFDA

Sun Pharmaceuticals Industries has received a communication from the US FDA releasing a copy of the Establishment Inspection Report (EIR) in respect of the inspection of Company's Dadra facility. Earlier, the USFDA had issued Form- 483 observation letter post inspection completed on 13 April 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, October 11 2017. 19:56 IST